{"entity":{"type":"insider","cik":"0001843189","url":"/insider/0001843189","json_url":"/insider/0001843189.json","name":"Walkey Carl","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":24,"first":"2021-02-05","last":"2021-06-17","span_basis":"filed_date"},"name_variants":[{"name":"Walkey Carl","source":"filing","n_filings":24,"first_seen":"2021-02-05","last_seen":"2021-06-17"}],"transactions":[{"id":4181261,"accession":"0001209191-21-041814","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-041814","line_url":"/filing/0001209191-21-041814#line-1","is_derivative":false,"issuer_cik":"0001404644","issuer_name":"Neoleukin Therapeutics, Inc.","issuer_ticker":"NLTX","issuer_name_source":null,"issuer_url":"/issuer/0001404644","owner_cik":"0001843189","owner_name":"Walkey Carl","owner_display_name":"Walkey Carl","owner_url":"/insider/0001843189","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":10.19,"price_display":"10.19","price_state":"stated","total_value":6114.0,"total_display":"6,114.00","total_whole":"6,114","shares_owned_after":1352489.0,"shares_owned_after_display":"1,352,489","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-16","filed_date":"2021-06-17","scope":"insider"},{"id":4377102,"accession":"0001209191-21-039819","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-039819","line_url":"/filing/0001209191-21-039819#line-1","is_derivative":false,"issuer_cik":"0001404644","issuer_name":"Neoleukin Therapeutics, Inc.","issuer_ticker":"NLTX","issuer_name_source":null,"issuer_url":"/issuer/0001404644","owner_cik":"0001843189","owner_name":"Walkey Carl","owner_display_name":"Walkey Carl","owner_url":"/insider/0001843189","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":650.0,"shares_display":"650","price_per_share":10.8246,"price_display":"10.82","price_state":"stated","total_value":7035.99,"total_display":"7,035.99","total_whole":"7,036","shares_owned_after":1353089.0,"shares_owned_after_display":"1,353,089","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-09","filed_date":"2021-06-11","scope":"insider"},{"id":4937998,"accession":"0001209191-21-039223","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-039223","line_url":"/filing/0001209191-21-039223#line-1","is_derivative":false,"issuer_cik":"0001404644","issuer_name":"Neoleukin Therapeutics, Inc.","issuer_ticker":"NLTX","issuer_name_source":null,"issuer_url":"/issuer/0001404644","owner_cik":"0001843189","owner_name":"Walkey Carl","owner_display_name":"Walkey Carl","owner_url":"/insider/0001843189","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":6600.0,"total_display":"6,600.00","total_whole":"6,600","shares_owned_after":1353739.0,"shares_owned_after_display":"1,353,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-08","filed_date":"2021-06-09","scope":"insider"},{"id":5398833,"accession":"0001209191-21-038696","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-038696","line_url":"/filing/0001209191-21-038696#line-1","is_derivative":false,"issuer_cik":"0001404644","issuer_name":"Neoleukin Therapeutics, Inc.","issuer_ticker":"NLTX","issuer_name_source":null,"issuer_url":"/issuer/0001404644","owner_cik":"0001843189","owner_name":"Walkey Carl","owner_display_name":"Walkey Carl","owner_url":"/insider/0001843189","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":6000.0,"total_display":"6,000.00","total_whole":"6,000","shares_owned_after":1354339.0,"shares_owned_after_display":"1,354,339","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-04","filed_date":"2021-06-07","scope":"insider"},{"id":4093519,"accession":"0001209191-21-036057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-036057","line_url":"/filing/0001209191-21-036057#line-1","is_derivative":false,"issuer_cik":"0001404644","issuer_name":"Neoleukin Therapeutics, Inc.","issuer_ticker":"NLTX","issuer_name_source":null,"issuer_url":"/issuer/0001404644","owner_cik":"0001843189","owner_name":"Walkey Carl","owner_display_name":"Walkey Carl","owner_url":"/insider/0001843189","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":6000.0,"total_display":"6,000.00","total_whole":"6,000","shares_owned_after":1354939.0,"shares_owned_after_display":"1,354,939","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-26","filed_date":"2021-05-26","scope":"insider"},{"id":4338427,"accession":"0001209191-21-035020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-035020","line_url":"/filing/0001209191-21-035020#line-1","is_derivative":false,"issuer_cik":"0001404644","issuer_name":"Neoleukin Therapeutics, Inc.","issuer_ticker":"NLTX","issuer_name_source":null,"issuer_url":"/issuer/0001404644","owner_cik":"0001843189","owner_name":"Walkey Carl","owner_display_name":"Walkey Carl","owner_url":"/insider/0001843189","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":10.63,"price_display":"10.63","price_state":"stated","total_value":6378.0,"total_display":"6,378.00","total_whole":"6,378","shares_owned_after":1355539.0,"shares_owned_after_display":"1,355,539","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-19","filed_date":"2021-05-21","scope":"insider"},{"id":5100169,"accession":"0001209191-21-032244","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-032244","line_url":"/filing/0001209191-21-032244#line-1","is_derivative":false,"issuer_cik":"0001404644","issuer_name":"Neoleukin Therapeutics, Inc.","issuer_ticker":"NLTX","issuer_name_source":null,"issuer_url":"/issuer/0001404644","owner_cik":"0001843189","owner_name":"Walkey Carl","owner_display_name":"Walkey Carl","owner_url":"/insider/0001843189","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":11.09,"price_display":"11.09","price_state":"stated","total_value":13308.0,"total_display":"13,308.00","total_whole":"13,308","shares_owned_after":1354762.0,"shares_owned_after_display":"1,354,762","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-12","filed_date":"2021-05-12","scope":"insider"},{"id":5159621,"accession":"0001209191-21-030654","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-030654","line_url":"/filing/0001209191-21-030654#line-1","is_derivative":false,"issuer_cik":"0001404644","issuer_name":"Neoleukin Therapeutics, Inc.","issuer_ticker":"NLTX","issuer_name_source":null,"issuer_url":"/issuer/0001404644","owner_cik":"0001843189","owner_name":"Walkey Carl","owner_display_name":"Walkey Carl","owner_url":"/insider/0001843189","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":11.3,"price_display":"11.30","price_state":"stated","total_value":13560.0,"total_display":"13,560.00","total_whole":"13,560","shares_owned_after":1355962.0,"shares_owned_after_display":"1,355,962","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-05","filed_date":"2021-05-06","scope":"insider"},{"id":5250298,"accession":"0001209191-21-029342","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-029342","line_url":"/filing/0001209191-21-029342#line-1","is_derivative":false,"issuer_cik":"0001404644","issuer_name":"Neoleukin Therapeutics, Inc.","issuer_ticker":"NLTX","issuer_name_source":null,"issuer_url":"/issuer/0001404644","owner_cik":"0001843189","owner_name":"Walkey Carl","owner_display_name":"Walkey Carl","owner_url":"/insider/0001843189","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":12.58,"price_display":"12.58","price_state":"stated","total_value":30192.0,"total_display":"30,192.00","total_whole":"30,192","shares_owned_after":1357162.0,"shares_owned_after_display":"1,357,162","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-28","filed_date":"2021-04-30","scope":"insider"},{"id":5522057,"accession":"0001209191-21-028727","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-028727","line_url":"/filing/0001209191-21-028727#line-1","is_derivative":false,"issuer_cik":"0001404644","issuer_name":"Neoleukin Therapeutics, Inc.","issuer_ticker":"NLTX","issuer_name_source":null,"issuer_url":"/issuer/0001404644","owner_cik":"0001843189","owner_name":"Walkey Carl","owner_display_name":"Walkey Carl","owner_url":"/insider/0001843189","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":7800.0,"total_display":"7,800.00","total_whole":"7,800","shares_owned_after":1359562.0,"shares_owned_after_display":"1,359,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-26","filed_date":"2021-04-27","scope":"insider"},{"id":4784117,"accession":"0001209191-21-027971","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-027971","line_url":"/filing/0001209191-21-027971#line-1","is_derivative":false,"issuer_cik":"0001404644","issuer_name":"Neoleukin Therapeutics, Inc.","issuer_ticker":"NLTX","issuer_name_source":null,"issuer_url":"/issuer/0001404644","owner_cik":"0001843189","owner_name":"Walkey Carl","owner_display_name":"Walkey Carl","owner_url":"/insider/0001843189","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":11.98,"price_display":"11.98","price_state":"stated","total_value":21564.0,"total_display":"21,564.00","total_whole":"21,564","shares_owned_after":1360162.0,"shares_owned_after_display":"1,360,162","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-21","filed_date":"2021-04-22","scope":"insider"},{"id":5323269,"accession":"0001209191-21-027050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-027050","line_url":"/filing/0001209191-21-027050#line-1","is_derivative":false,"issuer_cik":"0001404644","issuer_name":"Neoleukin Therapeutics, Inc.","issuer_ticker":"NLTX","issuer_name_source":null,"issuer_url":"/issuer/0001404644","owner_cik":"0001843189","owner_name":"Walkey Carl","owner_display_name":"Walkey Carl","owner_url":"/insider/0001843189","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":12.22,"price_display":"12.22","price_state":"stated","total_value":21996.0,"total_display":"21,996.00","total_whole":"21,996","shares_owned_after":1361962.0,"shares_owned_after_display":"1,361,962","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-14","filed_date":"2021-04-16","scope":"insider"},{"id":5379706,"accession":"0001209191-21-026153","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-026153","line_url":"/filing/0001209191-21-026153#line-1","is_derivative":false,"issuer_cik":"0001404644","issuer_name":"Neoleukin Therapeutics, Inc.","issuer_ticker":"NLTX","issuer_name_source":null,"issuer_url":"/issuer/0001404644","owner_cik":"0001843189","owner_name":"Walkey Carl","owner_display_name":"Walkey Carl","owner_url":"/insider/0001843189","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":12.02,"price_display":"12.02","price_state":"stated","total_value":21636.0,"total_display":"21,636.00","total_whole":"21,636","shares_owned_after":1363762.0,"shares_owned_after_display":"1,363,762","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-07","filed_date":"2021-04-08","scope":"insider"},{"id":4423700,"accession":"0001209191-21-025767","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-025767","line_url":"/filing/0001209191-21-025767#line-1","is_derivative":false,"issuer_cik":"0001404644","issuer_name":"Neoleukin Therapeutics, Inc.","issuer_ticker":"NLTX","issuer_name_source":null,"issuer_url":"/issuer/0001404644","owner_cik":"0001843189","owner_name":"Walkey Carl","owner_display_name":"Walkey Carl","owner_url":"/insider/0001843189","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":7800.0,"total_display":"7,800.00","total_whole":"7,800","shares_owned_after":1365562.0,"shares_owned_after_display":"1,365,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-05","filed_date":"2021-04-06","scope":"insider"},{"id":5467801,"accession":"0001209191-21-024707","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-024707","line_url":"/filing/0001209191-21-024707#line-1","is_derivative":false,"issuer_cik":"0001404644","issuer_name":"Neoleukin Therapeutics, Inc.","issuer_ticker":"NLTX","issuer_name_source":null,"issuer_url":"/issuer/0001404644","owner_cik":"0001843189","owner_name":"Walkey Carl","owner_display_name":"Walkey Carl","owner_url":"/insider/0001843189","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":11.96,"price_display":"11.96","price_state":"stated","total_value":21528.0,"total_display":"21,528.00","total_whole":"21,528","shares_owned_after":1366162.0,"shares_owned_after_display":"1,366,162","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-31","filed_date":"2021-04-02","scope":"insider"},{"id":5147163,"accession":"0001209191-21-022929","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-022929","line_url":"/filing/0001209191-21-022929#line-2","is_derivative":false,"issuer_cik":"0001404644","issuer_name":"Neoleukin Therapeutics, Inc.","issuer_ticker":"NLTX","issuer_name_source":null,"issuer_url":"/issuer/0001404644","owner_cik":"0001843189","owner_name":"Walkey Carl","owner_display_name":"Walkey Carl","owner_url":"/insider/0001843189","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":11.9533,"price_display":"11.95","price_state":"stated","total_value":21515.94,"total_display":"21,515.94","total_whole":"21,516","shares_owned_after":1367962.0,"shares_owned_after_display":"1,367,962","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-24","filed_date":"2021-03-24","scope":"insider"},{"id":5147157,"accession":"0001209191-21-022929","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-022929","line_url":"/filing/0001209191-21-022929#line-1","is_derivative":false,"issuer_cik":"0001404644","issuer_name":"Neoleukin Therapeutics, Inc.","issuer_ticker":"NLTX","issuer_name_source":null,"issuer_url":"/issuer/0001404644","owner_cik":"0001843189","owner_name":"Walkey Carl","owner_display_name":"Walkey Carl","owner_url":"/insider/0001843189","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":7200.0,"total_display":"7,200.00","total_whole":"7,200","shares_owned_after":1369762.0,"shares_owned_after_display":"1,369,762","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-22","filed_date":"2021-03-24","scope":"insider"},{"id":5094144,"accession":"0001209191-21-021946","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-021946","line_url":"/filing/0001209191-21-021946#line-1","is_derivative":false,"issuer_cik":"0001404644","issuer_name":"Neoleukin Therapeutics, Inc.","issuer_ticker":"NLTX","issuer_name_source":null,"issuer_url":"/issuer/0001404644","owner_cik":"0001843189","owner_name":"Walkey Carl","owner_display_name":"Walkey Carl","owner_url":"/insider/0001843189","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":11.36,"price_display":"11.36","price_state":"stated","total_value":13632.0,"total_display":"13,632.00","total_whole":"13,632","shares_owned_after":1370362.0,"shares_owned_after_display":"1,370,362","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-17","filed_date":"2021-03-18","scope":"insider"},{"id":4984605,"accession":"0001209191-21-019776","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-019776","line_url":"/filing/0001209191-21-019776#line-1","is_derivative":false,"issuer_cik":"0001404644","issuer_name":"Neoleukin Therapeutics, Inc.","issuer_ticker":"NLTX","issuer_name_source":null,"issuer_url":"/issuer/0001404644","owner_cik":"0001843189","owner_name":"Walkey Carl","owner_display_name":"Walkey Carl","owner_url":"/insider/0001843189","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":11.9667,"price_display":"11.97","price_state":"stated","total_value":21540.06,"total_display":"21,540.06","total_whole":"21,540","shares_owned_after":1371562.0,"shares_owned_after_display":"1,371,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-10","filed_date":"2021-03-11","scope":"insider"},{"id":4925882,"accession":"0001209191-21-017994","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-017994","line_url":"/filing/0001209191-21-017994#line-1","is_derivative":false,"issuer_cik":"0001404644","issuer_name":"Neoleukin Therapeutics, Inc.","issuer_ticker":"NLTX","issuer_name_source":null,"issuer_url":"/issuer/0001404644","owner_cik":"0001843189","owner_name":"Walkey Carl","owner_display_name":"Walkey Carl","owner_url":"/insider/0001843189","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":11.8667,"price_display":"11.87","price_state":"stated","total_value":21360.06,"total_display":"21,360.06","total_whole":"21,360","shares_owned_after":1373362.0,"shares_owned_after_display":"1,373,362","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-03","filed_date":"2021-03-04","scope":"insider"},{"id":4717258,"accession":"0001209191-21-014513","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-014513","line_url":"/filing/0001209191-21-014513#line-2","is_derivative":false,"issuer_cik":"0001404644","issuer_name":"Neoleukin Therapeutics, Inc.","issuer_ticker":"NLTX","issuer_name_source":null,"issuer_url":"/issuer/0001404644","owner_cik":"0001843189","owner_name":"Walkey Carl","owner_display_name":"Walkey Carl","owner_url":"/insider/0001843189","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":7800.0,"total_display":"7,800.00","total_whole":"7,800","shares_owned_after":1375162.0,"shares_owned_after_display":"1,375,162","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-25","filed_date":"2021-02-25","scope":"insider"},{"id":4717255,"accession":"0001209191-21-014513","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-014513","line_url":"/filing/0001209191-21-014513#line-1","is_derivative":false,"issuer_cik":"0001404644","issuer_name":"Neoleukin Therapeutics, Inc.","issuer_ticker":"NLTX","issuer_name_source":null,"issuer_url":"/issuer/0001404644","owner_cik":"0001843189","owner_name":"Walkey Carl","owner_display_name":"Walkey Carl","owner_url":"/insider/0001843189","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":12.14,"price_display":"12.14","price_state":"stated","total_value":21852.0,"total_display":"21,852.00","total_whole":"21,852","shares_owned_after":1375762.0,"shares_owned_after_display":"1,375,762","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-24","filed_date":"2021-02-25","scope":"insider"},{"id":5092235,"accession":"0001209191-21-011834","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-011834","line_url":"/filing/0001209191-21-011834#line-1","is_derivative":false,"issuer_cik":"0001404644","issuer_name":"Neoleukin Therapeutics, Inc.","issuer_ticker":"NLTX","issuer_name_source":null,"issuer_url":"/issuer/0001404644","owner_cik":"0001843189","owner_name":"Walkey Carl","owner_display_name":"Walkey Carl","owner_url":"/insider/0001843189","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":12.7,"price_display":"12.70","price_state":"stated","total_value":30480.0,"total_display":"30,480.00","total_whole":"30,480","shares_owned_after":1377562.0,"shares_owned_after_display":"1,377,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-17","filed_date":"2021-02-18","scope":"insider"},{"id":4924954,"accession":"0001209191-21-010148","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-010148","line_url":"/filing/0001209191-21-010148#line-1","is_derivative":false,"issuer_cik":"0001404644","issuer_name":"Neoleukin Therapeutics, Inc.","issuer_ticker":"NLTX","issuer_name_source":null,"issuer_url":"/issuer/0001404644","owner_cik":"0001843189","owner_name":"Walkey Carl","owner_display_name":"Walkey Carl","owner_url":"/insider/0001843189","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":14.2,"price_display":"14.20","price_state":"stated","total_value":42600.0,"total_display":"42,600.00","total_whole":"42,600","shares_owned_after":1379962.0,"shares_owned_after_display":"1,379,962","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-10","filed_date":"2021-02-12","scope":"insider"},{"id":4821622,"accession":"0001209191-21-008839","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-008839","line_url":"/filing/0001209191-21-008839#line-1","is_derivative":false,"issuer_cik":"0001404644","issuer_name":"Neoleukin Therapeutics, Inc.","issuer_ticker":"NLTX","issuer_name_source":null,"issuer_url":"/issuer/0001404644","owner_cik":"0001843189","owner_name":"Walkey Carl","owner_display_name":"Walkey Carl","owner_url":"/insider/0001843189","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":8400.0,"total_display":"8,400.00","total_whole":"8,400","shares_owned_after":1382962.0,"shares_owned_after_display":"1,382,962","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-05","filed_date":"2021-02-09","scope":"insider"},{"id":4526226,"accession":"0001209191-21-008129","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-008129","line_url":"/filing/0001209191-21-008129#line-1","is_derivative":false,"issuer_cik":"0001404644","issuer_name":"Neoleukin Therapeutics, Inc.","issuer_ticker":"NLTX","issuer_name_source":null,"issuer_url":"/issuer/0001404644","owner_cik":"0001843189","owner_name":"Walkey Carl","owner_display_name":"Walkey Carl","owner_url":"/insider/0001843189","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":13.23,"price_display":"13.23","price_state":"stated","total_value":31752.0,"total_display":"31,752.00","total_whole":"31,752","shares_owned_after":1383562.0,"shares_owned_after_display":"1,383,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-03","filed_date":"2021-02-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":26,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":26,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":26},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001404644","name":"Neoleukin Therapeutics, Inc.","url":"/issuer/0001404644","role":"Officer (Senior Vice President)","n_filings":24,"first_seen":"2021-02-05","last_seen":"2021-06-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001843189","retrieved_at":"2026-08-25T22:25:02+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}